Arkolith/Insider Trading/FBRX/Form 4

Wagner Paul A.

See Remarks, DirectorForte Biosciences, Inc. (FBRX) · full profile →Form 4 · filed Nov 22, 2023
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2023Buy(P)400$0.43$1721.7M
Nov 20, 2023Buy(P)5K$0.44$2K1.7M
Nov 20, 2023Buy(P)100$0.43$431.7M
Nov 20, 2023Buy(P)2K$0.43$6731.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-056522) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML